Portal - Live Events

AstraZeneca Lung

Blueprint Medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, healthier lives. Our approach combines our leading expertise in protein kinases with sound execution and an intense focus on discovery.

We maintain a diverse and growing portfolio of research programs, moving multiple investigational medicines through clinical development for patients with a broad range of genomically defined cancers and rare diseases.

Boehringer Ingelheim

Bristol Myers Squibb - Hematology

Covis Pharma

Eisai Oncology

Eli Lilly

Exact Sciences

Guardant Health

We are dedicated to helping patients at all stages of cancer live longer and healthier, through the power of blood tests and the data they unlock. Today our FDA-approved test helps inform treatment decisions for patients with advanced cancer. Our tests also detect residual and recurrent disease for patients with early-stage cancer, and will soon screen to find cancer at its earliest and most treatable.

Janssen Pharmaceuticals, Inc.

Merck Oncology

Natera

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.

http://www.natera.com

Novartis

http://www.novartis.com

Radiologic Resources, Inc

Sanofi-Genzyme

Takeda

Viatris Pharmaceuticals

2021 HYBRID Lung Cancer and Head & Neck Cancer Symposium